why choose us

Clinical Trials Search

Showing 15,340 of 132,656 result(s)
Chronic Postsurgical Pain

Status: NOT_YET_RECRUITING

Condition: Cerebral Palsy

Interventions:

Date: 2023-02-02

PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-Exposure Prophylaxis (PrEP)

Status: Completed

Condition: Hiv Prevention

Interventions: Participants will receive either Truvada or Descovy (based on prescription guidelines).

Date: 2023-02-02

A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

Status: Completed

Condition: Recurrent Acute Leukemia of Ambiguous Lineage

Interventions: Undergo collection of blood and bone marrow samples

Date: 2023-02-02

Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy

Status: Completed

Condition: Hemorrhage

Interventions: Single arm, healthy adult volunteers for blood donation.

Date: 2023-02-02

Domvanalimab and Zimberelimab in Advanced Liver Cancers

Status: Completed

Condition: Hepatobiliary Cancer

Interventions: Zimberelimab 360 mg IV every 3 weeks until disease progression, unacceptable toxicity, death, or discontinuation from the study treatment for any othe

Date: 2023-02-02

A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment

Status: Completed

Condition: Mild Cognitive Impairment

Interventions: dual-task tai ji quan training

Date: 2023-02-02

Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis

Status: NOT_YET_RECRUITING

Condition: Recurrent Acute Pancreatitis

Interventions: 40Mg Oral Tablet

Date: 2023-02-02

QOL and Sarcopenia in Patients With Ascites

Status: Completed

Condition: Ascites Hepatic

Interventions: QoL and sarcopenia assessments

Date: 2023-02-02

CPAP Adherence Pilot Study Among African Americans

Status: Completed

Condition: Sleep Apnea

Interventions: Text messages of encouragement will be sent to patients and partners.
No more than 2 messages will be sent per week to prevent respondent fatigue

Date: 2023-02-02

Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal

Status: Completed

Condition: Abdominal Cancer

Interventions: One tumor will be injected with 1 ug LPS (investigational drug) over approximately one minute

Date: 2023-02-02